Recent Quotes

My Watchlist

Indicators

Markets:

Overview

News

Currencies

International

Treasuries

Pacific Biosciences of California, Inc. - Common Stock (NQ:PACB)

1.350 +0.050 (+3.85%)

Streaming Delayed Price Updated: 4:00 PM EDT, Sep 14, 2026 Add to My Watchlist

Price and Volume

Detailed Quote

Volume	4,717,373
Open	1.280
Bid (Size)	1.300 (3,000)
Ask (Size)	1.340 (1,100)
Prev. Close	1.300
Today's Range	1.280 - 1.378
52wk Range	1.070 - 2.730
Shares Outstanding	247,079,374
Dividend Yield	N/A

Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News

3 Cash-Burning Stocks We Approach with Caution

Today 0:35 EDT

Rapid spending isn’t always a sign of progress. Some cash-burning businesses fail to convert investments into meaningful competitive advantages, leaving them...

Via StockStory

Q2 Earnings Highlights: PacBio (NASDAQ:PACB) Vs The Rest Of The Life Sciences Tools & Services Stocks

September 07, 2026

Quarterly earnings results are a good time to check in on a company’s progress, especially compared to its peers in the same sector. Today we are looking at ...

Via StockStory

Performance

YTD	-26.6%	-26.6%
1 Month	+17.4%	+17.4%
3 Month	+2.3%	+2.3%
6 Month	-0.7%	-0.7%
1 Year	+12.5%	+12.5%

More News

3 Reasons to Sell PACB and 1 Stock to Buy Instead

September 02, 2026

Via StockStory

1 of Wall Street’s Favorite Stocks to Own for Decades and 2 We Brush Off

August 26, 2026

Via StockStory

Pacific Biosciences (NASDAQ:PACB) Shares Drop After Q2 Revenue Miss ↗

August 05, 2026

Via Chartmill

1 Healthcare Stock to Target This Week and 2 Facing Headwinds

August 24, 2026

Via StockStory

PacBio Cuts Outlook as SPRQ-Nx Transition Slows, Targets 2028 Cash-Flow Positivity ↗

August 16, 2026

Via MarketBeat

5 Must-Read Analyst Questions From PacBio’s Q2 Earnings Call

August 12, 2026

Via StockStory

PACB Q2 Deep Dive: Leadership Transition and SPRQ-Nx Rollout Shape Outlook

August 06, 2026

Via StockStory

Pacific Biosciences of California Q2 Earnings Call Highlights ↗

August 06, 2026

Via MarketBeat

PacBio (NASDAQ:PACB) Reports Sales Below Analyst Estimates In Q2 CY2026 Earnings

August 05, 2026

Via StockStory

PacBio (PACB) To Report Earnings Tomorrow: Here Is What To Expect

August 03, 2026

Via StockStory

3 Russell 2000 Stocks That Fall Short

July 31, 2026

Via StockStory

1 Russell 2000 Stock on Our Watchlist and 2 That Underwhelm

July 30, 2026

Via StockStory

1 Small-Cap Stock Worth Investigating and 2 That Underwhelm

July 17, 2026

Via StockStory

3 of Wall Street’s Favorite Stocks Walking a Fine Line

July 03, 2026

Via StockStory

3 Cash-Burning Stocks with Questionable Fundamentals

July 01, 2026

Via StockStory

3 Unprofitable Stocks That Concern Us

June 15, 2026

Via StockStory

Q1 Earnings Highs And Lows: PacBio (NASDAQ:PACB) Vs The Rest Of The Life Sciences Tools & Services Stocks

June 01, 2026

Via StockStory

3 Russell 2000 Stocks Walking a Fine Line

May 29, 2026

Via StockStory

Blank Bio Announces Seed Financing and Strategic Collaboration with PacBio to Advance RNA Foundation Models for Precision Oncology

May 19, 2026

From Blank Bio

Via Business Wire

1 Stock Under $10 to Keep an Eye On and 2 We Avoid

May 18, 2026

Via StockStory

Why PacBio (PACB) Shares Are Getting Obliterated Today

May 08, 2026

Via StockStory

PacBio (PACB) Q1 2026 Earnings Call Transcript ↗

May 08, 2026

Via The Motley Fool

PACB Q1 Deep Dive: Consumables Growth and Clinical Adoption Offset Instrument Weakness

May 08, 2026

Via StockStory

Frequently Asked Questions

Is Pacific Biosciences of California, Inc. - Common Stock publicly traded?

Yes, Pacific Biosciences of California, Inc. - Common Stock is publicly traded.

What exchange does Pacific Biosciences of California, Inc. - Common Stock trade on?

Pacific Biosciences of California, Inc. - Common Stock trades on the Nasdaq Stock Market

What is the ticker symbol for Pacific Biosciences of California, Inc. - Common Stock?

The ticker symbol for Pacific Biosciences of California, Inc. - Common Stock is PACB on the Nasdaq Stock Market

What is the current price of Pacific Biosciences of California, Inc. - Common Stock?

The current price of Pacific Biosciences of California, Inc. - Common Stock is 1.350

When was Pacific Biosciences of California, Inc. - Common Stock last traded?

The last trade of Pacific Biosciences of California, Inc. - Common Stock was at 09/14/26 04:00 PM ET

What is the market capitalization of Pacific Biosciences of California, Inc. - Common Stock?

The market capitalization of Pacific Biosciences of California, Inc. - Common Stock is 333.56M

How many shares of Pacific Biosciences of California, Inc. - Common Stock are outstanding?

Pacific Biosciences of California, Inc. - Common Stock has 334M shares outstanding.

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.